• EAACI
  • Events
  • Professionals
  • Patients
  • News
Become a Member
Become a Member

EAACI Congress 2024 Back

31 May - 03 June 2024 Valencia, Spain

Tair Lapidot

Israel

Tair Lapidot

Dr. Tair Lapidot has served as Nasus Pharma Vice President of R&D and Clinical Development since 2019. For more than 20 years she has been leading scientific and clinical projects in the Israeli Life-Science industry. She holds Ph.D. in Biochemistry from the Hebrew University of Jerusalem.

Sessions

Sunday 2 Jun
15:00 - 15:12 Comparative phase 2 bioavailability study of a fast acting, dry powder-based, epinephrine intra-nasal formulation, FMXIN002, for anaphylaxis
×